Page last updated: 2024-08-21

pyrazines and Inappropriate GH Secretion Syndrome (Acromegaly)

pyrazines has been researched along with Inappropriate GH Secretion Syndrome (Acromegaly) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caumo, A; Lanzi, R; Losa, M; Mignogna, G; Pontiroli, AE1
Casanueva, FF; Cordido, F; Dieguez, C; Martinez, T; PeƱalva, A1

Trials

2 trial(s) available for pyrazines and Inappropriate GH Secretion Syndrome (Acromegaly)

ArticleYear
The control on growth hormone release by free fatty acids is maintained in acromegaly.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:4

    Topics: Acromegaly; Adult; Aged; Fatty Acids, Nonesterified; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Middle Aged; Pyrazines; Thyrotropin-Releasing Hormone

1999
Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
    Clinical endocrinology, 2001, Volume: 54, Issue:4

    Topics: Acromegaly; Adenoma; Area Under Curve; Fatty Acids, Nonesterified; Feedback; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Niacin; Pituitary Neoplasms; Pyrazines; Statistics, Nonparametric

2001